Skip to main content
Home
  • About
    • Board of Directors
    • Our Staff
    • Annual Reports
    • Policies
    • Fellowship
    • Careers
  • Projects
    • Column 1
      • Animal Health & Veterinary Medicine
        • Antimicrobial Use in Food Animals
        • Cross-Sectoral Health Threats
        • Industry SWOT Analysis
      • Expanded Access
        • E-request App
        • Navigator
        • Resources for COVID-19
      • FDA Patient Listening Sessions
      • Food & Nutrition
        • About
        • Food Traceability
        • Healthy Rule Roundtables
        • Nutrition Facts Label
        • Produce Safety Stakeholder Dialogue
        • Retail Dietitian Toolkit
    • Column 2
      • Improving Access to FDA Information
        • Understanding FDA & FDA-Regulated Products
        • Improving Access to Publicly Available FDA Information
      • Research
        • About
        • IMEDS
          • IMEDS Inquiry
        • Post Market Research
        • RAISE
        • Real World Data
        • Regulatory Science Accelerator
      • Substance Use Disorders
  • News and Events
    • Innovations in Regulatory Science & Policy Awards
    • 2025 Annual Public Meeting
    • Events
    • News
    • Publications
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
      1. Board of Directors
      2. Our Staff
      3. Annual Reports
      4. Policies
      5. Fellowship
      6. Careers
  • Projects
      1. Column 1
        1. Animal Health & Veterinary Medicine
          1. Antimicrobial Use in Food Animals
          2. Cross-Sectoral Health Threats
          3. Industry SWOT Analysis
        2. Expanded Access
          1. E-request App
          2. Navigator
          3. Resources for COVID-19
        3. FDA Patient Listening Sessions
        4. Food & Nutrition
          1. About
          2. Food Traceability
          3. Healthy Rule Roundtables
          4. Nutrition Facts Label
          5. Produce Safety Stakeholder Dialogue
          6. Retail Dietitian Toolkit
      2. Column 2
        1. Improving Access to FDA Information
          1. Understanding FDA & FDA-Regulated Products
          2. Improving Access to Publicly Available FDA Information
        2. Research
          1. About
          2. IMEDS
          3. Post Market Research
          4. RAISE
          5. Real World Data
          6. Regulatory Science Accelerator
        3. Substance Use Disorders
  • News and Events
      1. Innovations in Regulatory Science & Policy Awards
      2. 2025 Annual Public Meeting
      3. Events
      4. News
      5. Publications
  • Expanded Access eRequest

Fourth Dose of mRNA COVID-19 Vaccine in Residents of LTCFs

  • Read more about Fourth Dose of mRNA COVID-19 Vaccine in Residents of LTCFs

Gut Microbiota Profile and Its Impact on Immunity Status in COVID-19 Vaccinated Cohorts

  • Read more about Gut Microbiota Profile and Its Impact on Immunity Status in COVID-19 Vaccinated Cohorts

Accelerated TMS for Depression and OCD

  • Read more about Accelerated TMS for Depression and OCD

Medical Triage in a Time of Scarce Resources.

  • Read more about Medical Triage in a Time of Scarce Resources.

Echinacea Drug for Covid-19

  • Read more about Echinacea Drug for Covid-19

Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19

  • Read more about Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19

Women s Health Awareness Community Resiliency, Environmental Action and Collaborations for Health (REACH) Equity

  • Read more about Women s Health Awareness Community Resiliency, Environmental Action and Collaborations for Health (REACH) Equity

Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)

  • Read more about Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)

The Effect of Virtual Reality Exercises on Patients With Post-SARS-CoV-2 Syndrome

  • Read more about The Effect of Virtual Reality Exercises on Patients With Post-SARS-CoV-2 Syndrome

Efficacy, Immunogenicity and Safety of BBIBP-CorV Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.

  • Read more about Efficacy, Immunogenicity and Safety of BBIBP-CorV Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 204
  • Page 205
  • Page 206
  • Page 207
  • Current page 208
  • Page 209
  • Page 210
  • Page 211
  • Page 212
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
admin@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA